Oncoclinicas do Brasil Market Cap ($122.40 Million)
Market Cap & Net Worth: Oncoclinicas do Brasil (ONCO3)
Oncoclinicas do Brasil market cap. Oncoclinicas do Brasil (SA:ONCO3) has a market capitalization of $122.40 Million (R$623.80 Million) as of October 31, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #18279 globally and #172 in its home market, demonstrating a -32.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncoclinicas do Brasil's stock price R$0.71 by its total outstanding shares 878588947 (878.59 Million).
Oncoclinicas do Brasil Market Cap History (2021–2026)
Oncoclinicas do Brasil market cap history from 2021 to 2026. Data shows change from $1.94 Billion to $122.40 Million (-46.77% CAGR). Check Oncoclinicas do Brasil stock quote for real-time trading data and today's change.
Oncoclinicas do Brasil Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncoclinicas do Brasil's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see ONCO3 cash flow metrics for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.06x
Oncoclinicas do Brasil's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.94 Billion | $2.70 Billion | -$46.90 Million | 0.72x | N/A |
| 2022 | $1.04 Billion | $4.09 Billion | $46.26 Million | 0.25x | 22.47x |
| 2023 | $2.24 Billion | $5.49 Billion | $223.62 Million | 0.41x | 10.02x |
| 2024 | $403.40 Million | $6.23 Billion | -$646.19 Million | 0.06x | N/A |
Competitor Companies of ONCO3 by Market Capitalization
Companies near Oncoclinicas do Brasil in the global market cap rankings as of October 31, 2026. See ONCO3 net asset quality score to understand what proportion of total assets are financed by equity.
Key companies related to Oncoclinicas do Brasil by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #290 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #907 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #993 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1215 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #290 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $478.08 |
| #907 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.00 |
| #993 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1215 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $270.57 |
Market Capitalization of Oncoclinicas do Brasil (2021–2026)
Market capitalization of Oncoclinicas do Brasil from 2021 to today. Between 2021 and today, Oncoclinicas do Brasil's market cap moved from $1.94 Billion to $ 122.40 Million, with a yearly change of -46.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$122.40 Million | -73.80% |
| 2025 | R$467.19 Million | +15.81% |
| 2024 | R$403.40 Million | -82.00% |
| 2023 | R$2.24 Billion | +115.59% |
| 2022 | R$1.04 Billion | -46.40% |
| 2021 | R$1.94 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Oncoclinicas do Brasil was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $122.40 Million USD |
| MoneyControl | $122.40 Million USD |
| MarketWatch | $122.40 Million USD |
| marketcap.company | $122.40 Million USD |
| Reuters | $122.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oncoclinicas do Brasil
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more